{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:05:28Z","timestamp":1761609928587},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T00:00:00Z","timestamp":1510358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T00:00:00Z","timestamp":1510358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10067-017-3906-0","type":"journal-article","created":{"date-parts":[[2017,11,11]],"date-time":"2017-11-11T14:47:27Z","timestamp":1510411647000},"page":"927-933","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["IRAK2 is associated with susceptibility to rheumatoid arthritis"],"prefix":"10.1007","volume":"37","author":[{"given":"Hana Ben","family":"Hassine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rim","family":"Sghiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyes","family":"Chabchoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Boumiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foued","family":"Slama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Baccouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahid","family":"Shakoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel","family":"Almogren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Mariaselvam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryad","family":"Tamouza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyes","family":"Bouajina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramzi","family":"Zemni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,11]]},"reference":[{"key":"3906_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.it.2013.01.004","volume":"34","author":"SC Sun","year":"2013","unstructured":"Sun SC, Chang JH, Jin J (2013) Regulation of NF-kB in autoimmunity. Trends Immunol 34:282\u2013289","journal-title":"Trends Immunol"},{"key":"3906_CR2","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.4049\/jimmunol.176.9.5652","volume":"176","author":"ML Cho","year":"2006","unstructured":"Cho ML, Kang JW, Moon YM et al (2006) STAT3 and NF-kB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1receptor antagonist- deficient mice. J Immunol 176:5652\u20135661","journal-title":"J Immunol"},{"key":"3906_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","volume":"28","author":"XO Yang","year":"2008","unstructured":"Yang XO, Pappu BP, Nurieva R et al (2008) T helper17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28:29\u201339","journal-title":"Immunity"},{"key":"3906_CR4","doi-asserted-by":"publisher","first-page":"5668","DOI":"10.1073\/pnas.96.10.5668","volume":"96","author":"J Bondeson","year":"1999","unstructured":"Bondeson J, Foxwell B, Brennan F et al (1999) Defining therapeutic targets by using adenovirus: blocking NF-kB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci U S A 96:5668\u20135673","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3906_CR5","doi-asserted-by":"publisher","first-page":"13859","DOI":"10.1073\/pnas.95.23.13859","volume":"95","author":"AV Miagkov","year":"1998","unstructured":"Miagkov AV, Kovalenko DV, Brown CE et al (1998) NF-kB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci U S A 95:13859\u201313864","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3906_CR6","first-page":"253","volume":"2","author":"R Medzhitov","year":"1998","unstructured":"Medzhitov R, Preston-Hurlburt P, Kopp E et al (1998) MyD88 is an adaptor protein in the Toll\/IL-1 receptor family signaling pathways. Cell 2:253\u2013258","journal-title":"Cell"},{"key":"3906_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0167-4889(02)00320-8","volume":"1592","author":"MU Martin","year":"2002","unstructured":"Martin MU, Wesche H (2002) Summary and comparison of the signaling mechanisms of the Toll\/interleukin-1 receptor family. Biochim Biophys Acta 1592:265\u2013280","journal-title":"Biochim Biophys Acta"},{"key":"3906_CR8","first-page":"1341","volume":"286","author":"J George","year":"2011","unstructured":"George J, Motshwene PG, Wang H et al (2011) Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly. J BiolChem 286:1341\u20131353","journal-title":"J BiolChem"},{"key":"3906_CR9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.it.2010.12.005","volume":"32","author":"NJ Gay","year":"2011","unstructured":"Gay NJ, Gangloff M, O\u2019Neill LA (2011) What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol 32:104\u2013109","journal-title":"Trends Immunol"},{"key":"3906_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/35092578","volume":"413","author":"KA Fitzgerald","year":"2001","unstructured":"Fitzgerald KA, Palsson-McDermott EM, Bowie AG et al (2001) Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78\u201383","journal-title":"Nature"},{"key":"3906_CR11","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1126\/science.278.5343.1612","volume":"278","author":"M Muzio","year":"1997","unstructured":"Muzio M, Ni J, Feng P et al (1997) IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278:1612\u20131615","journal-title":"Science"},{"key":"3906_CR12","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.4049\/jimmunol.1203268","volume":"191","author":"E Pauls","year":"2013","unstructured":"Pauls E, Nanda SK, Smith H et al (2013) Two phases of inflammatory mediator production defined by the study of IRAK2 and IRAK1 knock-in mice. J Immunol 191:2717\u20132730","journal-title":"J Immunol"},{"key":"3906_CR13","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/MD.0b013e3181fd8ec3","volume":"89","author":"C Picard","year":"2010","unstructured":"Picard C, von Bernuth H, Ghandil P et al (2010) Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine 89:403\u2013425","journal-title":"Medicine"},{"key":"3906_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jbspin.2010.05.013","volume":"77","author":"A Chatzikyriakidou","year":"2010","unstructured":"Chatzikyriakidou A, Voulgari PV, Georgiou I et al (2010) A polymorphism in the 3\u2032-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine 77:411\u2013413","journal-title":"Joint Bone Spine"},{"key":"3906_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/art.37804","volume":"65","author":"TU Han","year":"2013","unstructured":"Han TU, Cho SK, Kim T et al (2013) Association of an activity-enhancing variant of IRAK1 and an MECP2-IRAK1 haplotype with increased susceptibility to rheumatoid arthritis. Arthritis Rheum 65:590\u201359810","journal-title":"Arthritis Rheum"},{"key":"3906_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1089\/gtmb.2016.0270","volume":"1","author":"HB Hassine","year":"2017","unstructured":"Hassine HB, Boumiza A, Sghiri R et al (2017) Micro RNA-146a but not IRAK1 is associated with rheumatoid arthritis in the Tunisian population. Genet Test Mol Biomarkers 1:92\u201396","journal-title":"Genet Test Mol Biomarkers"},{"key":"3906_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/annrheumdis-2012-201851","volume":"72","author":"KM Kaufman","year":"2013","unstructured":"Kaufman KM, Zhao J, Kelly JA et al (2013) Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemiclupus erythematosus in multiple ancestral groups. Ann Rheum Dis 72:437\u2013444","journal-title":"Ann Rheum Dis"},{"key":"3906_CR18","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1136\/annrheumdis-2012-202742","volume":"12","author":"FD Carmona","year":"2013","unstructured":"Carmona FD, C\u00e9nit MC, Diaz-Gallo LM et al (2013) New insight on the Xq28 association with systemic sclerosis. Ann Rheum Dis 12:2032\u20132038","journal-title":"Ann Rheum Dis"},{"key":"3906_CR19","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/hep.28105","volume":"62","author":"H Wang","year":"2015","unstructured":"Wang H, El Maadidi S, Fischer J et al (2015) Hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance. Hepatology 62:1375\u20131387","journal-title":"Hepatology"},{"key":"3906_CR20","first-page":"12507","volume":"289","author":"W Zhang","year":"2014","unstructured":"Zhang W, He T, Wang Q et al (2014) Interleukin-1 receptor-associated kinase-2 genetic variant rs708035 increases NF-\u03baB activity through promoting TRAF6 ubiquitination. J BiolChem 289:12507\u201312519","journal-title":"J BiolChem"},{"key":"3906_CR21","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/ European League against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581","journal-title":"Arthritis Rheum"},{"key":"3906_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000022901","volume":"50","author":"JH Zhao","year":"2000","unstructured":"Zhao JH, Curtis D, Sham PC (2000) Model-free analysis and permutation tests for allelic associations. Hum Hered 50:133\u2013139","journal-title":"Hum Hered"},{"key":"3906_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","volume":"43","author":"AJ MacGregor","year":"2000","unstructured":"MacGregor AJ, Snieder H, Rigby AS et al (2000) Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 43:30\u201337","journal-title":"Arthritis Rheum"},{"key":"3906_CR24","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/art.24385","volume":"60","author":"D van der Woude","year":"2009","unstructured":"van der Woude D, Houwing-Duistermaat JJ, Toes RE et al (2009) Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum 60:916\u2013923","journal-title":"Arthritis Rheum"},{"key":"3906_CR25","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1399-0004.1989.tb03185.x","volume":"36","author":"CM Deighton","year":"1989","unstructured":"Deighton CM, Walker DJ, Griffiths ID et al (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36:178\u2013182","journal-title":"Clin Genet"},{"key":"3906_CR26","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/ng.2462","volume":"44","author":"S Eyre","year":"2013","unstructured":"Eyre S, Bowes J, Diogo D et al (2013) High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 44:1336\u20131340","journal-title":"Nat Genet"},{"key":"3906_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada Y, Wu D, Trynka G et al (2014) Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506:376\u2013381","journal-title":"Nature"},{"key":"3906_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.autrev.2009.04.006","volume":"9","author":"P Szodoray","year":"2010","unstructured":"Szodoray P, Szabo Z, Kapitany A et al (2010) Anti-citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 9:140\u2013143","journal-title":"Autoimmun Rev"},{"key":"3906_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrrheum.2011.117","volume":"7","author":"L Davila","year":"2011","unstructured":"Davila L, Ranganathan P (2011) Pharmacogenetics: implications for therapy in rheumatic diseases. Nat Rev Rheumatol 7:537\u2013550","journal-title":"Nat Rev Rheumatol"},{"key":"3906_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/art.30130","volume":"63","author":"D Plant","year":"2011","unstructured":"Plant D, Bowes J, Potter C et al (2011) Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum 63:645\u2013653","journal-title":"Arthritis Rheum"},{"key":"3906_CR31","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.bcp.2010.06.020","volume":"80","author":"S Flannery","year":"2010","unstructured":"Flannery S, Bowie AG (2010) The interleukin-1 receptor-associated kinases: critical regulators of innate immune signalling. Biochem Pharmacol 80:1981\u20131991","journal-title":"Biochem Pharmacol"},{"key":"3906_CR32","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/ni.1606","volume":"9","author":"T Kawagoe","year":"2008","unstructured":"Kawagoe T, Sato S, Matsushita K et al (2008) Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat Immunol 9:684\u2013691","journal-title":"Nat Immunol"},{"key":"3906_CR33","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature00888","volume":"418","author":"H Ye","year":"2002","unstructured":"Ye H, Arron JR, Lamothe B et al (2002) Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418:443\u2013447","journal-title":"Nature"},{"key":"3906_CR34","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.4049\/jimmunol.164.8.4301","volume":"164","author":"JL Swantek","year":"2000","unstructured":"Swantek JL, Tsen MF, Cobb MH et al (2000) IL-1 receptor associated kinase modulates host responsiveness to endotoxin. J Immunol 164:4301\u20134306","journal-title":"J Immunol"},{"key":"3906_CR35","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.1074\/jbc.M807822200","volume":"284","author":"Y Wan","year":"2009","unstructured":"Wan Y, Xiao H, Affolter J et al (2009) Interleukin-1 receptor associated kinase 2 is critical for lipopolysaccharide-mediated post-transcriptional control. J Biol Chem 284:10367\u201310375","journal-title":"J Biol Chem"},{"key":"3906_CR36","doi-asserted-by":"crossref","unstructured":"Flannery SM, Keating SE, Szymak J. Human interleukin-1 receptor\u2013associated kinase-2 is essential for Toll-like receptor\u2013mediated transcriptional and post-transcriptional regulation of tumor necrosis factor alpha. J Biol Chem 286:23688\u201323697","DOI":"10.1074\/jbc.M111.248351"},{"key":"3906_CR37","first-page":"33435","volume":"282","author":"SE Keating","year":"2007","unstructured":"Keating SE, Maloney GM, Moran EM et al (2007) IRAK2 participates in multiple toll-like receptor signaling pathways to NF kappa B via activation of TRAF6 ubiquitination. J BiolChem 282:33435\u201333443","journal-title":"J BiolChem"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-017-3906-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3906-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3906-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T01:53:15Z","timestamp":1659059595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-017-3906-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,11]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["3906"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3906-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,11]]},"assertion":[{"value":"31 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Farhat Hached University Hospital ethics committee. Participants were enrolled in the study after obtaining their informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}